Exercise for Chronic Pediatric Conditions
(Project REACH Trial)
Trial Summary
What is the purpose of this trial?
This study is a cooperative investigation funded by the NIH. The project is a collaboration among three major NIH Clinical Translational Science Awardees: 1) UCI (lead site with its affiliate CHOC), 2) Northwestern University (with its affiliate Lurie Children's Hospital), and 3) USC (with its affiliate Children's Hospital of Los Angeles). There is an increasing number of children who, through medical advances, now survive diseases and conditions that were once fatal, but which remain chronic and debilitating. A major challenge to improve both the immediate and long term care and health of such children has been the gap in our understanding of how to assess the biological effects of exercise. Like otherwise healthy children, children with chronic diseases and disabilities want to be physically active. The challenge is to determine what constitutes safe and beneficial level of physical activity when the underlying disease or condition \[e.g., cystic fibrosis (CF) or sickle cell disease (SCD)\] imposes physiological constraints on exercise that are not present in otherwise healthy children. Current exercise testing protocols were based on studies of athletes and high performing healthy individuals and were designed to test limits of performance at very high-intensity, unphysiological, maximal effort. These approaches are not optimal for children and adolescents with disease and disability. This project (REACH-Revamping Exercise Assessment in Child Health) is designed to address this gap. Cohorts of children will be identified with two major genetic diseases (CF and SCD) and measure exercise responses annually as they progress from early puberty to mid or late puberty over a 3-4year period. In addition, in the light of the pandemic, a group of children will be added who were affected by SARS-CoV-2 and investigate their responses to exercise. SARS-CoV-2 has similar long-term symptoms than CF and SCD have. Novel approaches to assessing physiological responses to exercise using advanced data analytics will be examined in relation to metrics of habitual physical activity, circulating biomarkers of inflammation and growth, leukocyte gene expression, and the impact of the underlying CF, SCD or SARS-CoV-2 condition. The data from this study will help to develop a toolkit of innovative metrics for exercise testing that will be made available to the research and clinical community.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that chronic medication use is an exclusion criterion for healthy controls and those with a history of SARS-CoV-2 infection. It's best to discuss your specific medications with the trial coordinators.
What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for chronic pediatric conditions?
Research shows that exercise can improve fitness levels and muscle strength in children with chronic conditions. For example, a study found that setting specific fitness goals led to significant improvements in cardiorespiratory fitness and strength in children at risk of metabolic issues. Additionally, tailored exercise interventions have been shown to enhance exercise capacity, endurance, and quality of life in children with various chronic diseases.12345
Is exercise safe for children with chronic conditions?
Exercise is generally safe for children, including those with chronic conditions like congenital heart disease, when done appropriately. Studies show that exercise can help improve physical fitness and is recommended by health authorities, but it's important to follow specific guidelines and consult with healthcare providers.678910
How is exercise different from other treatments for chronic pediatric conditions?
Exercise is unique because it not only helps alleviate symptoms of chronic conditions but also improves a child's overall quality of life and psychosocial development. Unlike medications, exercise can enhance physical fitness, reduce body fat, and improve functional ability, making it a holistic approach to managing chronic diseases in children.1112131415
Eligibility Criteria
Children aged approximately 10-17 with cystic fibrosis, sickle cell disease, or past SARS-CoV-2 infection are eligible for this exercise study if they're in good health and have no other conditions that limit physical activity. They must be at a stage of puberty as defined by Tanner stages 1-5 and have physician approval to perform exercise tests.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Cardiopulmonary Exercise Test (CPET) to measure cardiorespiratory responses, with blood sampling at multiple time points
Follow-up
Participants are monitored for safety and effectiveness after treatment, including gene expression and body composition assessments
Treatment Details
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor
Children's Hospital of Orange County
Collaborator
Children's Hospital Los Angeles
Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Children's Hospital of Orange County (CHOC)
Collaborator
Children's Hospital of Los Angeles (CHLA)
Collaborator
Lurie Children's Hospital in Chicago
Collaborator